These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34480991)

  • 1. The role of fatty acids in Crohn's disease pathophysiology - An overview.
    Piotrowska M; Binienda A; Fichna J
    Mol Cell Endocrinol; 2021 Dec; 538():111448. PubMed ID: 34480991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.
    Parada Venegas D; De la Fuente MK; Landskron G; González MJ; Quera R; Dijkstra G; Harmsen HJM; Faber KN; Hermoso MA
    Front Immunol; 2019; 10():277. PubMed ID: 30915065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Free Fatty Acid Receptor 4 Affects Intestinal Inflammation and Improves Colon Permeability in Mice.
    Salaga M; Bartoszek A; Binienda A; Krajewska JB; Fabisiak A; Mosińska P; Dziedziczak K; Niewinna K; Talar M; Tarasiuk A; Kordek R; Fichna J
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free Fatty Acid Receptors as new potential therapeutic target in inflammatory bowel diseases.
    Bartoszek A; Moo EV; Binienda A; Fabisiak A; Krajewska JB; Mosińska P; Niewinna K; Tarasiuk A; Martemyanov K; Salaga M; Fichna J
    Pharmacol Res; 2020 Feb; 152():104604. PubMed ID: 31846762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
    Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
    Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free Fatty Acid Receptors in Health and Disease.
    Kimura I; Ichimura A; Ohue-Kitano R; Igarashi M
    Physiol Rev; 2020 Jan; 100(1):171-210. PubMed ID: 31487233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-Chain Fatty Acid Receptors and Cardiovascular Function.
    Lymperopoulos A; Suster MS; Borges JI
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free fatty acid receptors as therapeutic targets for the treatment of diabetes.
    Ichimura A; Hasegawa S; Kasubuchi M; Kimura I
    Front Pharmacol; 2014; 5():236. PubMed ID: 25414667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel antidiabetic therapy: free fatty acid receptors as potential drug target.
    Sekiguchi H; Kasubuchi M; Hasegawa S; Pelisch N; Kimura I; Ichimura A
    Curr Diabetes Rev; 2015; 11(2):107-15. PubMed ID: 25732031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free Fatty Acid Receptors as Mediators and Therapeutic Targets in Liver Disease.
    Secor JD; Fligor SC; Tsikis ST; Yu LJ; Puder M
    Front Physiol; 2021; 12():656441. PubMed ID: 33897464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
    Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.
    Gonçalves P; Araújo JR; Di Santo JP
    Inflamm Bowel Dis; 2018 Feb; 24(3):558-572. PubMed ID: 29462379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary fatty acid content influences the expression of genes involved in the lipid turnover and inflammation in mouse colon and spleen.
    Mosińska P; Tarasiuk A; Fabisiak A; Krajewska J; Niewinna K; Bartoszek A; Binienda A; Sałaga M; Fichna J
    Pharmacol Rep; 2019 Oct; 71(5):899-908. PubMed ID: 31421543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free Fatty Acid Receptors (FFARs) in Adipose: Physiological Role and Therapeutic Outlook.
    Al Mahri S; Malik SS; Al Ibrahim M; Haji E; Dairi G; Mohammad S
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease.
    Liu Y; Wang X; Hu CA
    Nutrients; 2017 Aug; 9(9):. PubMed ID: 28832517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the IL23/IL17 Pathway in Crohn's Disease.
    Schmitt H; Neurath MF; Atreya R
    Front Immunol; 2021; 12():622934. PubMed ID: 33859636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From sensing to shaping microbiota: insights into the role of NOD2 in intestinal homeostasis and progression of Crohn's disease.
    Balasubramanian I; Gao N
    Am J Physiol Gastrointest Liver Physiol; 2017 Jul; 313(1):G7-G13. PubMed ID: 28450278
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon.
    Christiansen CB; Gabe MBN; Svendsen B; Dragsted LO; Rosenkilde MM; Holst JJ
    Am J Physiol Gastrointest Liver Physiol; 2018 Jul; 315(1):G53-G65. PubMed ID: 29494208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propionate catabolism by CD-associated adherent-invasive
    Agus A; Richard D; Faïs T; Vazeille E; Chervy M; Bonnin V; Dalmasso G; Denizot J; Billard E; Bonnet R; Buisson A; Barnich N; Delmas J
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33769191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of adipose tissue in the pathogenesis of Crohn's disease.
    Zielińska A; Siwiński P; Sobolewska-Włodarczyk A; Wiśniewska-Jarosińska M; Fichna J; Włodarczyk M
    Pharmacol Rep; 2019 Feb; 71(1):105-111. PubMed ID: 30513401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.